» Articles » PMID: 36816695

Antibacterial and Antibiofilm Activities of Sertindole and Its Antibacterial Mechanism Against

Overview
Journal ACS Omega
Specialty Chemistry
Date 2023 Feb 23
PMID 36816695
Authors
Affiliations
Soon will be listed here.
Abstract

As methicillin-resistant has become the most prevalent antibiotic-resistant pathogen in many countries, there is an urgent demand to develop novel antibacterial agents. The purpose of this study is to investigate sertindole's antibacterial and antibiofilm properties, as well as its antibacterial mechanism against . The MIC and MIC values for sertindole against were both determined to be 50 μM, and sertindole significantly reduced growth at a subinhibitory concentration of 1/2× MIC. Sertindole also showed remarkable potency in inhibiting the development of biofilms. Additionally, proteomic analysis revealed that sertindole could dramatically decrease the biosynthesis of amino acids and trigger the cell wall stress response and oxidative stress response. A series of tests, including membrane permeability assays, quantitative real-time reverse transcription-PCR, and electron microscope observations, revealed that sertindole disrupts cell integrity. The two-component system VraS/VraR knockout strain also showed enhanced sensitivity to sertindole. Overall, our data suggested that sertindole exhibited antibacterial and biofilm-inhibiting activities against and that its antibacterial actions may involve the destruction of cell integrity.

Citing Articles

Repurposing TAK-285 as An Antibacterial Agent against Multidrug-Resistant Staphylococcus aureus by Targeting Cell Membrane.

Huang J, Xu Z, He P, Lin Z, Peng R, Yu Z Curr Microbiol. 2024; 82(1):8.

PMID: 39585416 DOI: 10.1007/s00284-024-04001-3.


Targeting Staphylococcal Cell-Wall Biosynthesis Protein FemX Through Steered Molecular Dynamics and Drug-Repurposing Approach.

Rahman S, Nath S, Mohan U, Das A ACS Omega. 2023; 8(32):29292-29301.

PMID: 37599983 PMC: 10433341. DOI: 10.1021/acsomega.3c02691.

References
1.
Hafer C, Lin Y, Kornblum J, Lowy F, Uhlemann A . Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 2012; 56(11):5845-51. PMC: 3486570. DOI: 10.1128/AAC.01139-12. View

2.
Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K . Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol. 2003; 49(3):807-21. DOI: 10.1046/j.1365-2958.2003.03599.x. View

3.
Ippolito G, Leone S, Lauria F, Nicastri E, Wenzel R . Methicillin-resistant Staphylococcus aureus: the superbug. Int J Infect Dis. 2010; 14 Suppl 4:S7-11. DOI: 10.1016/j.ijid.2010.05.003. View

4.
Shin J, Park S, Kim E, Jo Y, Hong J, Cho D . Sertindole, a potent antagonist at dopamine D₂ receptors, induces autophagy by increasing reactive oxygen species in SH-SY5Y neuroblastoma cells. Biol Pharm Bull. 2012; 35(7):1069-75. DOI: 10.1248/bpb.b12-00009. View

5.
Nosengo N . Can you teach old drugs new tricks?. Nature. 2016; 534(7607):314-6. DOI: 10.1038/534314a. View